A week ago, Kuehne + Nagel International AG (VTX:KNIN) came out with a strong set of third-quarter numbers that could potentially lead to a re-rate of the stock. It was overall a positive result, with revenues beating expectations by 7.4% to hit CHF7.4b. Kuehne + Nagel International reported statutory earnings per share (EPS) CHF2.57, which was a notable 10% above what the analysts had forecast. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Kuehne + Nagel International after the latest results.
Taking into account the latest results, the most recent consensus for Kuehne + Nagel International from 16 analysts is for revenues of CHF27.0b in 2027. If met, it would imply a credible 5.5% increase on its revenue over the past 12 months. Per-share earnings are expected to ascend 19% to CHF9.83. Yet prior to the latest earnings, the analysts had been anticipated revenues of CHF26.1b and earnings per share (EPS) of CHF9.60 in 2027. It looks like there's been a modest increase in sentiment following the latest results, withthe analysts becoming a bit more optimistic in their predictions for both revenues and earnings.
Check out our latest analysis for Kuehne + Nagel International
Althoughthe analysts have upgraded their earnings estimates, there was no change to the consensus price target of CHF215, suggesting that the forecast performance does not have a long term impact on the company's valuation. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. There are some variant perceptions on Kuehne + Nagel International, with the most bullish analyst valuing it at CHF250 and the most bearish at CHF166 per share. As you can see, analysts are not all in agreement on the stock's future, but the range of estimates is still reasonably narrow, which could suggest that the outcome is not totally unpredictable.
These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Kuehne + Nagel International's past performance and to peers in the same industry. One thing stands out from these estimates, which is that Kuehne + Nagel International is forecast to grow faster in the future than it has in the past, with revenues expected to display 4.3% annualised growth until the end of 2027. If achieved, this would be a much better result than the 9.8% annual decline over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in the industry are forecast to see their revenue grow 1.7% per year. Not only are Kuehne + Nagel International's revenues expected to improve, it seems that the analysts are also expecting it to grow faster than the wider industry.
The Bottom Line
The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards Kuehne + Nagel International following these results. Happily, they also upgraded their revenue estimates, and are forecasting them to grow faster than the wider industry. The consensus price target held steady at CHF215, with the latest estimates not enough to have an impact on their price targets.
Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have forecasts for Kuehne + Nagel International going out to 2028, and you can see them free on our platform here.
Before you take the next step you should know about the 1 warning sign for Kuehne + Nagel International that we have uncovered.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.